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At moderate iodination levels (20 iodine at atoms/molecule), human thyroglobulin (hTgb) produces after 
reduction a thyroxinyl-peptide of 26 kDa which represents the N-terminal part of the protein. At higher 
iodination levels, the 26-kDa peptide is accompanied by another T,-containing peptide of 18 kDa. A precur- 
sor-product relationship between the 26- and 18-kDa fragments was demonstrated by the study of the trypt- 
ic fragments of both hormonopeptides. In addition, comparison with the protein sequence deduced from 
the nucleotide sequence of the 5’-end of hTgb mRNA demonstrated that the N-terminal region of Htgb 
from which are issued the 26-kDa peptide and its ll-kDa derivative is especially sensitive to proteolysis. 
This character is possibly related with a facilitated release of thyroid hormones in vivo. 
Human thyroglobulin Thyroxine-containingpeptide 
1. INTRODUCTION 
Thyroglobulin (Tgb), the high-molecular dime- 
ric glycoprotein (2 x 330 kDa) of the thyroid gland, 
is the support of thyroid hormone synthesis, T4 
and Ts. Indeed, the hormones are formed by iodi- 
nation of certain tyrosine residues of the protein 
and the oxidative coupling of some of the resulting 
iodotyrosyl residues. Iodination of Tgb provokes 
different modifications of the physico-chemical 
properties of the molecule, e.g., change in the 
sedimentation coefficient, decrease in the 
dissociability into subunits and change in its 
susceptibility to proteases. Recently another 
characteristic of Tgb in relation to iodination was 
evidenced: the presence of peptides of small 
molecular mass (9-45 kDa) rich in hormones and 
associated to the bulk of the molecule by disulfide 
bridges. This was demonstrated in the Tgb of dif- 
Abbreviations: hTgb, human thyroglobulin; MIT, 
3-iodotyrosine; DIT, 3,5-diiodotyrosine; T+ thyroxine; 
TFA, trifluoroacetic acid 
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ferent species iodinated in vivo or in vitro [l-7]. It 
was also demonstrated for some of them that they 
originated from the cleavage of the peptide chain, 
presumably in relation with iodination and/or hor- 
mone synthesis [6,8]. In hTgb, two hormonopep- 
tides of 26 kDa and 18 kDa were characterized 
[4,6]. In a previous paper [6], we have 
demonstrated that the 26-kDa peptide represented 
the N-terminal part of the Tgb chain and that the 
T4 residue in this fragment was located in position 
5 from the N-terminal Asn residue. This 
T4-forming site is extremely active since it forms 
approx. 50% of the total T4 when the hTgb con- 
tains 20 I atoms/molecule. By progressive iodina- 
tion of poorly iodinated hTgb in vitro, we have 
also demonstrated [6] that the amount of the 
26-kDa peptide was maximum when the molecule 
had bound 20 I atoms/molecule and decreased for 
higher iodination levels, whereas the 18-kDa 
species increased in parallel to become the main 
component for hTgb preparations containing 60 I 
atoms/molecule. 
To broaden our knowledge of the structure- 
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function relationship in hTgb, it was important to 
specify whether the 1%kDa hormonopeptide con- 
tained a hormone-forming site different from the 
site identified in the 26-kDa peptide and was only 
operative at high iodination levels or whether the 
18-kDa species originated from the 26-kDa peptide 
by peptide bond cleavage and derived from the 
same part of the hTgb molecule. 
Here, thanks to the study of the tryptic peptides 
of these two hormonopeptides and by comparing 
their amino acid sequences with that deduced from 
the sequencing of the hTgb mRNA [9], we 
demonstrate unambiguously: (1) a precursor- 
product relationship between the 26- and 18-kDa 
species; (2) that the N-terminal segment of hTgb 
from which these peptides originate is especially 
sensitive to peptide bond cleavage, a characteristic 
possibly related to a facilitated release of thyroid 
hormone in vivo. 
2. MATERIALS AND METHODS 
2.1. Thyroglobulin preparation 
Undegraded poorly iodinated hTgb (4 I 
atoms/molecule) was purified from a human col- 
loid goiter as in [IO]. 
2.2. Thyroglobulin iodination 
Poorly iodinated hTgb was iodinated as in [6] 
using the amount of KI necessary to incorporate 
about 60 I atoms/molecule. Excess iodide was 
eliminated by dialysis and iodine incorporated in 
the protein was measured by iodoamino acid 
estimation [ 1 I]. 
2.3. Preparation of 26 and Id-kDa hormono- 
peptides 
After iodination to 56 I atoms/molecule, hTgb 
was reduced and S-carboxymethylated [6], then 
chromatographed on Biogel A-5m in 0.05 M 
Tris-Cl, 8 M urea, pH 7.6. The retarded fraction 
was refiltered on Ultrogel AcA 54 in 0.2 M 
NHdHCO3. 
2.4. Tryptic digestion 
The 26- and 18-kDa peptides (1% in 0.2 M 
NH4HC03,pH 8.6) were digested for 4 h at 37°C 
with trypsin-TPCK (Worthington, Freehold, 
USA) at an enzyme to substrate ratio of 1:25 
(w/w). The digest was then adjusted to pH 3.0 with 
acetic acid. The precipitate (acid core) was 
separated by centrifugation and the supernatant 
preserved for further analysis. 
2.5. Purification of the tryptic peptides 
The tryptic digest supernatant was filtered on 
Biogel P-6 in 0.2 M NH4HCO3 and each group of 
peptides was analyzed by high performance liquid 
chromatography (HPLC) (Waters, Milford, USA) 
on a Lichrosorb RP-18 column (4 x 250 mm, 7 pm 
particle size). A linear gradient was applied with an 
initial solvent (A) of 1% NH4HC03 and a second 
solvent (B) of 100% CHJCN from 5-60%(B) for 
45 min at a flow-rate of 0.8 ml/min. Column 
Iodine atoms / Mol Tgb 
20 56 
10-3.Mr 
26 
Fig. 1. SDS-PAGE of poorly iodinated (4 I atoms/ 
molecule) before and after iodination in vitro (20 and 56 
I atoms/molecule). 50 lg protein per gel (8% polyacryl- 
amide) were analyzed after reduction by 1% 
dithiothreitol for 3 min at 100°C. 
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eluates were continuously monitored for absor- 
bance at 230 nm. Peptides from the acid core were 
first dissolved in 6 M guanidine .HCI and purified 
on the same column using a linear gradient formed 
of solvent(A),O,O5~~ aqueous TFA and sol- 
vent(B)CH&N,O.OS% TFA for 50 min from 
IO-55% B at a flow rate of 1 ml/min. 
2.6. Sequence analysis 
Automated N-terminal sequencing of the 
1%kDa peptide was performed in a 890 C 
Beckman Sequenator using the 0.1 M quadrol pro- 
gram. The manual microsequencing method of 
1121 which allows the identification of hormone 
residues f13] was used for N-terminal sequencing 
of the I8-kDa and all the purified tryptic peptides. 
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2.7. Other techniques 
Amino acid analyses were performed in a model 
4101 LKB amino acid analyzer after hydrolysis in 
6 N HCl, 0.5070 thiogly~olic acid for 20 h in sealed 
evacuated tubes. Separation and quantitative 
estimation of iodoamino acids were carried out as 
in [ll] and polyacrylamide gel electrophoresis 
(PAGE) as in [S]. 
3. RESULTS AND DISCUSSION 
Analysis by SDS-PAGE of poorly iodinated 
hTgb after reduction and before and after the in- 
corporation of 20 and 56 I atoms/molecule shows 
(fig. 1) the absence of 18- and 26-kDa fragments in 
poorly iodinated hTgb and their appearance after 
iodination of the protein. Both peptides were 
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Fig. 2(A) Filtration on Biogel A-5m of reduced and S-carboxymethylated hTgb after iodination in vitro (56 I atoms/ 
molecule). 400 mg protein were layered on a 2.6 x 90 cm column equilibrated and eluted with 0.05 M Tris-Cl, 8 M urea, 
pH 7.6. Flow-rate, 8 ml/h, volume of fractions, 2 ml. Tubes were pooled according to arrows to give fractions I, II. 
(B) Filtration on Ultrogel AcA 54 of fraction II (see A). 30 mg protein were layered on a 2.6 x 90 cm column equilibrated 
and eluted with 0.2 M NHdHC03. 26- and IS-kDa fractions were pooled according to arrows. Inset: SDS-PAGE of 
26- and l&kDa fractions in 8% gel. 
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Fig. 3. HPLC analysis of the acid core of the tryptic 
digest of the 26 kDa peptide. Approximately 500 1.18 pro- 
tein dissolved in 200 81 6 M guanidine. HCf (Gnd) were 
injected into a Lichrosorb RP-18 column. Elution condi- 
tions: mobile phase, (A) 0.05% aqueous TFA, (B) 
CHjCN, 0.05% TFA; linear 50 min gradient from 
lo-55070 (B). Flow-rate, 1 mf/min. 
! 
i . 
1 
i .-.-...-. 
Fig. 5. Filtration on Biogel P-6 of the tryptic digest of 
the 18 kDa supernatant. Same conditions as in.Fig. 3. 
1.2 mg protein was applied to the column. 
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Fig. 4. Filtration on Biogel P-6 of the tryptic digest of 
the 26 kDa supernatant. About 2.2 mg protein was ap- 
plied on a 1 x 30 cm column equilibrated and eluted in 
0.2 M N&HCOs. Fraction volume, 0.8 ml. Flow-rate, 
Fig. 6. HPLC analysis of fraction III of the tryptic digest 
of the 26 kDa peptide (see fig. 4). Approx. 250 pg pro- 
tein were injected into a Lichrosorb RP-18 column. 
Mobile phase: (A) 1% N&HCOj, (B) 100% CHsCN, 
linear 45 min gradient from 5-60% (B). The elution 
positions of the tryptic peptides T!, T;, T2, Tr3 and T$ 
8 ml/h. Fractions were pooled according to arrows. are indicated by arrows. 
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Fig. 7. Sequence of the first 260 amino acids from the N-terminal end of hTgb as deduced from the nucleotide sequence 
of its mRNA [9]. Residues are numbered from the N-terminal amino acid (Asn) of the 26- and 18-kDa peptides. TI-TI~ 
are the theoretical tryptic peptides taking into account the specificity of trypsin. The vertical arrows indicate the actual 
bonds cleaved by trypsin in the 26- and 18-kDa fragments as deduced from analysis of the purified peptides. -. , amino 
acids identified by microsequencing; those underlined were identified by automatic sequencing of the 18-kDa peptide. 
TI, T?, T?, T2, T3, Td,Tf, T’S, TB, TC6, T9 were purified from the 18- and TI, T?, TP, T2, T3, T4, TS, T!, Tg, TIO, T13 
from 26-kDa fragment. The tyrosine residue in position 5 has been identified as T4 by micro-sequencing both in the 
26- and ll-kDa peptide. 
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purified from hTgb containing 56 I atoms/ 
molecule as described in the legend of fig. 2 and 
both contained only traces of MIT and DIT and 
close to 1 mol T4/mol. After microsequencing of 
the 18-kDa fragment, T4 was identified in the se- 
quence: Asn-Ile-Phe-Glu-T4-Gln-Val-, identical to 
the sequence determined in the 26-kDa peptide [61. 
This structure was confirmed by automatic sequen- 
cing of the 18-kDa peptide. This is a first evidence 
for the common origin of the two peptides. 
However, it has been suggested that homologous 
repeating segments might exist in the Tgb molecule 
[14-161. Moreover, study of the N-terminal part 
of the hTgb chain deduced by sequencing of DNA 
clones complementary to hTgb mRNA showed the 
presence of several homologous repeats in the 
nucleotide sequence [ 171. To confirm that the 
26-kDa peptide was actually the precursor of the 
18-kDa fragment, the tryptic peptides of these two 
fragments have been compared. 
After tryptic digestion of both peptides and 
acidification, the whole of T4 was recovered in the 
acid core as peptides T? and Ti (fig. 3). Purifica- 
tion on Biogel P-6 and HPLC (figs 4-6) of the acid 
soluble fraction of the digests of the 26- and 
18-kDa fragments allowed isolation of 12 peptides 
(T!, T2, J-3, T4, -IT, ‘-& Ts, T8, T:, T9, Tlo, T13) 
whose homogeneity was established by amino acid 
composition and micro-sequencing. 
Of the 14 peptides identified, 9 (TP, Ti, T!, Tz, 
T3, T4, T!, T!, T6) were found to be common to 
the hydrolysates of the 26- and 18-kDa fragments. 
In fig. 7, these peptides have been related to the se- 
quence of the N-terminal part of hTgb deduced 
from the nucleotide sequence of the 5 ‘-end of the 
hTgb mRNA as recently established by authors in 
[9]. Comparison with the results obtained by pro- 
tein sequencing of the 26-kDa peptide confirms 
our previous results [6] suggesting that the latter 
likely represented the N-terminal segment of hTgb; 
indeed, the 26-kDa peptide is preceded by a pep- 
tide of 19 amino acids whose size and 
hydrophobicity correspond to a signal peptide of 
secretion. 
Thus, the sequence of the first 133 amino acids 
of the N-terminal end of the hTgb chain is com- 
mon to the two hormonopeptides, demonstrating 
unambiguously that the 26-kDa peptide is the 
precursor of the 18-kDa fragment. 
However, since no amino acid was released by 
action of carboxypeptidases A, B and Y on the 26- 
or 18-kDa peptides, for digestion times of 30 and 
120 min at pH 8.6 or 6.0, it is difficult to specify 
the points of cleavage of the hTgb chain that pro- 
duce the 26-kDa segment and its derived 18-kDa 
product. 
On the other hand, study of the tryptic peptides 
of both fragments revealed several aspecific bonds 
of tryptic cleavage especially involving carbox- 
ymethylcysteinyl bonds. Indeed: (1) 90% of the 
T4-containing peptide Ti was recovered as T? in 
the acid core and T! in the acid-soluble fraction; 
(2) the totality of peptide Ts was cleaved at the car- 
boxymethylcysteinyl bond in position 73; (3) pep- 
tide T6 has been partially cleaved at glycylss and 
tryptophanyllzo bonds. 
It is possible that these bonds have been made 
more fragile by a special secondary structure of the 
chain at their level. Whatever the mechanism of 
these aspecific cleavages, it is worth relating the 
great susceptibility to peptide bond cleavage of this 
part of the molecule, which contains a very active 
T4-forming site, to the aptitude of Tgb to release 
the thyroid hormones easily. 
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